Skip to main content
. Author manuscript; available in PMC: 2015 May 29.
Published in final edited form as: Pediatr Nephrol. 2014 May 3;29(10):2021–2028. doi: 10.1007/s00467-014-2820-9

Table 3.

Cox proportional hazard regression for mortality risk by ESA category (n=820)

Hazard ratio 95 % confidence Interval p value
ESA category (U/kg/week)a
  1. No ESA 2.71 0.81–9.00 0.39
  2. EPO: 0 to <100/DARBO: 0 to <0.49 1.62 0.54–4.90 0.10
  3. EPO: 200 to <350/DARBO 1 to <1.5 1.81 0.67–4.87 0.24
  4. EPO ≥350/DARBO ≥1.5 3.37 1.37–8.26 0.01
Race
  Black vs white 1.36 0.77–2.41 0.29
  Other vs white 0.98 0.42–2.28 0.97
Diagnosis
  Urological vs other 0.42 0.21–0.81 0.01
  SLE vs other 0.43 0.97–1.90 0.27
  FSGS vs other 0.57 0.23–1.38 0.21
Hemoglobin≥11 g/dL (yes vs no) 0.79 0.47–1.33 0.37
Albumin≥3.5 g/dL BCG/3.2 g/dL BCP (yes vs no) 0.66 0.38–1.14 0.13
Dialysis modality
  HD AVG/AVF vs PD 0.47 0.17–1.27 0.14
  HD with catheter vs PD 2.14 1.19–3.86 0.01
Age (per 1 year increase) 0.91 0.86–0.96 0.001
Male vs female 1.3 0.76–2.23 0.34
Kt/V ≥1.2 (HD)/1.8 (PD) vs <1.2/1.8 0.63 0.32–1.23 0.01
Time on dialysis ≥1 year vs <1 year 1.26 0.73–2.19 0.40
a

ESA dose category EPO 100 to <200/DARBO 0.49 to 1.0 U/kg/week reference